Close

Kite Pharma (KITE) volatility at 104 into lymphoma drug trial meets primary endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BA
8. SNAP
9. TMUS
10. BSX


Go back to Kite Pharma (KITE) volatility at 104 into lymphoma drug trial meets primary endpoint